Sakuranetin downregulates inducible nitric oxide synthase expression by affecting interleukin-1 receptor and CCAAT/enhancer-binding protein β
Pruni Cortex is a herbal drug from the bark of the Japanese flowering cherries, Prunus jamasakura or Prunus verecunda, and is included in the traditional Japanese herbal (Kampo) formula Jumihaidokuto, which is administered orally to patients suffering from inflammatory skin diseases. The flavanones contained in Pruni Cortex (e.g., sakuranetin and naringenin) have potent anti-inflammatory, anti-allergic, and anti-microbial activities. Although the effects of Pruni Cortex on skin disease have been well studied, reports regarding its pharmacological effects on the liver are limited. In this study, we extracted the bark of Prunus jamasakura and purified it to isolate the pharmacologically active constituents by monitoring nitric oxide (NO) production in rat hepatocytes that were treated with the pro-inflammatory cytokine, interleukin (IL)-1β. Sakuranetin and (−)-naringenin, which were present in an ethyl acetate-soluble fraction of the bark extract, significantly inhibited NO induction and inducible nitric oxide synthase (iNOS) expression. These two flavanones decreased the expression of type 1 IL-1 receptor gene and phosphorylation of Akt, also known as protein kinase B, which is regulated by phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K). Furthermore, sakuranetin decreased the phosphorylation of the activator isoforms of CCAAT/enhancer-binding protein β (C/EBPβ), which synergistically activates the transcription of the iNOS gene with nuclear factor κB (NF-κB). Therefore, sakuranetin inhibited the co-activating activity of C/EBPβ with NF-κB, leading to the suppression of iNOS gene expression in hepatocytes. Taken together, sakuranetin in Pruni Cortex downregulated the iNOS gene by inhibiting PI3K/Akt signal transduction and the phosphorylation of C/EBPβ. These results imply that sakuranetin may be primarily responsible for the anti-inflammatory effects of Pruni Cortex in the liver.
KeywordsCherry bark Nitric oxide Kampo medicine Interleukin 1 receptor CCAAT/enhancer-binding protein β Nuclear factor κB
CCAAT/enhancer-binding protein β
Inducible nitric oxide synthase
Interleukin 1 receptor, type 1
Nuclear magnetic resonance
Quantitative reverse transcription–polymerase chain reaction
Elongation factor 1α
A activator-binding site
Liver-enriched activator protein
We thank Dr. Yuji Hasegawa for mass spectra analyses, Ms. Yuki Nakano for her technical assistance, and Ms. Noriko Kanazawa for her secretarial assistance. This work was supported in part by the Asia-Japan Research Institute of Ritsumeikan Asia-Japan Research Organization, Ritsumeikan University.
Compliance with ethical standards
Conflict of interest
Y. Yamauchi and T. Ishii performed this study as graduate students of the Graduate School of Life Sciences, Ritsumeikan University.
- 1.The Committee on the Japanese Pharmacopoeia (2016) The Japanese pharmacopoeia, 17th edn. The Minister of Health, Labour and Welfare, JapanGoogle Scholar
- 7.Watanabe K, Karuppagounder V, Arumugam S, Thandavarayan RA, Pitchaimani V, Sreedhar R, Afrin R, Harima M, Suzuki H, Suzuki K, Nakamura T, Nomoto M, Miyashita S, Fukumoto K, Ueno K (2015) Pruni cortex ameliorates skin inflammation possibly through HMGB1–NF-κB pathway in house dust mite induced atopic dermatitis NC/Nga transgenic mice. J Clin Biochem Nutr 56:186–194CrossRefGoogle Scholar
- 13.Kitade H, Sakitani K, Inoue K, Masu Y, Kawada N, Hiramatsu Y, Kamiyama Y, Okumura T, Ito S (1996) Interleukin 1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Hepatology 23:797–802Google Scholar
- 16.Miki H, Tokuhara K, Oishi M, Nakatake R, Tanaka Y, Kaibori M, Nishizawa M, Okumura T, Kon M (2016) Japanese Kampo Saireito has a liver-protective effect through the inhibition of inducible nitric oxide synthase induction in primary cultured rat hepatocytes. JPEN J Parenter Enteral Nutr 40:1033–1041CrossRefGoogle Scholar
- 23.Tanemoto R, Okuyama T, Matsuo H, Okumura T, Ikeya Y, Nishizawa M (2015) The constituents of licorice (Glycyrrhiza uralensis) differentially suppress nitric oxide production in interleukin-1β-treated hepatocytes. Biochem Biophys Rep 2:153–159. https://doi.org/10.1016/j.bbrep.2015.06.004 Google Scholar
- 28.Buss H, Dörrie A, Schmitz ML, Hoffmann E, Resch K, Kracht M (2004) Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 279:55633–55643CrossRefGoogle Scholar
- 32.Nakajima A, Yamamoto Y, Yoshinaka N, Namba M, Matsuo H, Okuyama T, Yoshigai E, Okumura T, Nishizawa M, Ikeya Y (2015) A new flavanone and other flavonoids from green perilla leaf extract inhibit nitric oxide production in interleukin 1β-treated hepatocytes. Biosci Biotechnol Biochem 79:138–146CrossRefGoogle Scholar
- 35.Kim KY, Kang H (2016) Sakuranetin inhibits inflammatory enzyme, cytokine, and costimulatory molecule expression in macrophages through modulation of JNK, p38, and STAT1. Evid Based Complement Alternat Med 2016:9824203Google Scholar